Bubs Australia Ltd. (AU:BUB) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Bubs Australia Ltd. has reported substantial growth in the U.S. market, with weekly revenue from infant formula sales exceeding US$1 million, making it the number one seller on Amazon USA in May 2024. The company is also making progress on the FDA’s permanent access pathway, with a significant portion of their clinical trial target enrollment achieved. Additionally, the Chinese market shows signs of recovery, with new product launches and expanded retail presence, setting a strong foundation for anticipated growth in FY25.
For further insights into AU:BUB stock, check out TipRanks’ Stock Analysis page.